1:
Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigò M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F.
J Autoimmune Dis. 2006 Oct 5;3:5.
PMID: 17022813 [PubMed]
Related Articles Free article in PMC
2:
Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigó M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F.
Ann N Y Acad Sci. 2007 Sep;1110:578-89.
PMID: 17911474 [PubMed - indexed for MEDLINE]
Related Articles
9:
Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial.
Bhushan M, Bleiker TO, Ballsdon AE, Allen MH, Sopwith M, Robinson MK, Clarke C, Weller RP, Graham-Brown RA, Keefe M, Barker JN, Griffiths CE.
Br J Dermatol. 2002 May;146(5):824-31.
PMID: 12000379 [PubMed - indexed for MEDLINE]
Related Articles
17:
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G.
Int J Mol Med. 2006 Sep;18(3):415-23.
PMID: 16865225 [PubMed - indexed for MEDLINE]
Related Articles